These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 23326143

  • 1. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
    Xue H, Zhang M, Pang JX, Yan F, Li YC, Lv LS, Yuan J, Palikhe M, Li WZ, Wang ZL.
    World J Gastroenterol; 2012 Dec 28; 18(48):7341-7. PubMed ID: 23326143
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
    Chen Y, Ma X, Zhang X, Luo J, An L, Zhang Y, Chang X, Dong Z, Zhang W, Kong H, Zhao J, Ding H, Liu F, Yang Y.
    Hepatol Int; 2022 Dec 28; 16(6):1379-1389. PubMed ID: 36255564
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions.
    Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M.
    Dig Dis Sci; 1998 Nov 28; 43(11):2463-9. PubMed ID: 9824135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
    Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, van Hoek B, Nicolai JJ, Kuipers EJ, Pattynama PM, van Buuren HR.
    Hepatology; 2016 Feb 28; 63(2):581-9. PubMed ID: 26517576
    [Abstract] [Full Text] [Related]

  • 9. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
    Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, Geiger R, Stiepak C, Keller W, Blum HE.
    Lancet; 1997 Apr 12; 349(9058):1043-9. PubMed ID: 9107241
    [Abstract] [Full Text] [Related]

  • 10. TIPS vs. endoscopic treatment for prevention of recurrent variceal bleeding: a long-term follow-up of 126 patients.
    Korsic S, Stabuc B, Skok P, Popovic P.
    Radiol Oncol; 2021 Jan 26; 55(2):164-171. PubMed ID: 33544525
    [Abstract] [Full Text] [Related]

  • 11. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.
    Orloff MJ, Hye RJ, Wheeler HO, Isenberg JI, Haynes KS, Vaida F, Girard B, Orloff KJ.
    Surgery; 2015 Jun 26; 157(6):1028-45. PubMed ID: 25957003
    [Abstract] [Full Text] [Related]

  • 12. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children.
    Lv Y, He C, Guo W, Yin Z, Wang J, Zhang B, Meng X, Cai J, Luo B, Wu F, Niu J, Fan D, Han G.
    J Pediatr Gastroenterol Nutr; 2016 Feb 26; 62(2):233-41. PubMed ID: 26381818
    [Abstract] [Full Text] [Related]

  • 13. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
    Pomier-Layrargues G, Villeneuve JP, Deschênes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP.
    Gut; 2001 Mar 26; 48(3):390-6. PubMed ID: 11171831
    [Abstract] [Full Text] [Related]

  • 14. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G.
    J Hepatol; 2017 Sep 26; 67(3):508-516. PubMed ID: 28506905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG, Perricone G, Robbins HL, Battula NR, Weickert MO, Sutton R, Khan S.
    Cochrane Database Syst Rev; 2020 Oct 22; 10(10):CD000553. PubMed ID: 33089892
    [Abstract] [Full Text] [Related]

  • 17. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
    Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B.
    J Gastroenterol Hepatol; 2020 Feb 22; 35(2):278-283. PubMed ID: 31222830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, Lin CK, Chan HH, Pan HB.
    Endoscopy; 2007 Aug 22; 39(8):679-85. PubMed ID: 17661241
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.